Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002254062 | SCV002525283 | uncertain significance | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV003164361 | SCV003863135 | uncertain significance | Cardiovascular phenotype | 2022-12-23 | criteria provided, single submitter | clinical testing | The p.H1128Y variant (also known as c.3382C>T), located in coding exon 21 of the SOS1 gene, results from a C to T substitution at nucleotide position 3382. The histidine at codon 1128 is replaced by tyrosine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003655351 | SCV004507914 | likely benign | RASopathy | 2023-02-10 | criteria provided, single submitter | clinical testing |